A5092597142- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Extracellular vesicles in disease
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Brain Metastases and Treatment
- Heart Failure Treatment and Management
- Liver Disease Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Research Studies
- Neuroendocrine Tumor Research Advances
- Dialysis and Renal Disease Management
Medical University of Warsaw
2023-2024
Transarterial chemoembolization (TACE) is used as a bridging treatment in liver transplant candidates with hepatocellular carcinoma (HCC). Alpha-fetoprotein (AFP) the main tumor marker for HCC surveillance. The aim of this study was to assess potential using AFP change after first TACE prediction complete necrosis. comprised 101 patients who underwent transplantation (LT) period between January 2011 and December 2020. ΔAFP defined difference value before either second or LT. receiver...
Background:Malignant and benign neuroendocrine tumors (NET) share many histopathological features.Liver transplantation (LT) is one of the liver-directed therapies for liver metastases (NELM).The aim this study was to determine outcomes patients undergoing LT NELM. Material/Methods:This a retrospective that included 19 who underwent unresectable NELM between December 1989 2022 in Department General, Transplant, Liver Surgery Medical University Warsaw.Kaplan-Meier estimator Cox proportional...
Risk stratification in heart failure with mildly-reduced ejection fraction (HFmrEF) remains challenging. We evaluated the predictive value of advanced glycation end products (AGEs) and plasma concentrations extracellular vesicles (EVs) for systolic diastolic dysfunction progression HFmrEF patients. Skin AGE accumulation was measured using Reader. Plasma EV were flow cytometry. Among 74 patients enrolled, 13 (18%) had 5 (7%) during 6.5 months follow-up. Leukocyte EVs higher (p = 0.002)...